webinar register page

Webinar banner
The Vaccine Race
How will a COVID-19 vaccine get to people around the world? What are the facets of development and manufacturing that are critical to its success?

Join Mark Tykocinski, MD, provost and executive vice president for Academic Affairs at Thomas Jefferson University and The Anthony F. and Gertrude M. DePalma Dean of the Sidney Kimmel Medical College, as he leads a discussion with our panel of experts exploring the end-to-end process of researching, developing, and delivering a vaccine:

Matthias Schnell, PhD
Director, Jefferson Vaccine Center
Professor and Chair, Microbiology & Immunology
Professor, Biochemistry & Molecular Biology
Thomas Jefferson University

Hanneke Schuitemaker, PhD
Global Head of Viral Vaccine Discovery and Translational Medicine
Disease Area Stronghold Leader for Viral Vaccines
Janssen Vaccines & Prevention

In this exclusive online talk for Jefferson, Textile, and Philadelphia University alumni sponsored by the Jefferson College of Life Sciences Alumni Association, Drs. Schnell and Schuitemaker share a look at the work being done in preclinical and clinical research and within the manufacturing industry in the global race to find a COVID-19 vaccine.

Nov 6, 2020 12:00 PM in Eastern Time (US and Canada)

* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register

Speakers

Matthias Schnell, PhD
Director, Jefferson Vaccine Center, and Professor/Chair, Microbiology & Immunology @Thomas Jefferson University
Dr. Schnell is Chair of the Department of Microbiology and Immunology and a professor in the Microbiology & Immunology and Biochemistry & Molecular Biology departments at the Sidney Kimmel Medical College at Thomas Jefferson University and is Director of the Jefferson Vaccine Center (JVC). He joined Thomas Jefferson University in 1998 following positions at the Federal Research Center for Virus Diseases of Animals in Tuebingen and Yale University. Dr. Schnell is a member of the American Society of Microbiology, American Association for the Advancement of Science, Infectious Diseases Society of America, International Society for Neurovirology, International Society for Vaccines, and The American Society of Gene & Cell Therapy, and has served on several editorial boards. For more, visit jefferson.edu/university/jmc/departments/microbiology/faculty_staff/faculty/schnell.html.
Hanneke Schuitemaker, PhD
Global Head of Viral Vaccine Discovery & Translational Medicine and Disease Area Stronghold Leader for Viral Vaccines @Janssen Vaccines & Prevention
Hanneke Schuitemaker, PhD, is the Head of Viral Vaccine Discovery and Translational Medicine and Disease Area Stronghold Leader for Viral Vaccines at Janssen Vaccines & Prevention B.V. In this role, she oversees Janssen’s viral vaccine programs including investigational vaccine candidates for HIV, respiratory syncytial virus (RSV), Ebola, Zika, SARS-CoV-2, and HPV. She has been in this role since 2010. In addition, she is a Professor of Virology at the Amsterdam University Medical Center.